Gene · 2043
Papers2,263
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,263
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differentiating Benign from Malignant Thyroid Tumors by Kinase Activity Profiling and Dabrafenib BRAF V600E Targeting. | Cancers (Basel) | 2023 | 37760447 | PubTator, text mining | PubMed |
| Drug repurposing for Alzheimer's disease from 2012-2022-a 10-year literature review. | Front Pharmacol | 2023 | 37745051 | PubTator, text mining | PubMed |
| Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer. | Biochem Biophys Res Commun | 2023 | 37741263 | PubTator, text mining | PubMed |
| Extracellular vesicle-cell adhesion molecules in tumours: biofunctions and clinical applications. | Cell Commun Signal | 2023 | 37735659 | PubTator, text mining | PubMed |
| The role and potential therapeutic targets of astrocytes in central nervous system demyelinating diseases. | Front Cell Neurosci | 2023 | 37720543 | PubTator, text mining | PubMed |
| Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice. | Dis Model Mech | 2023 | 37718909 | PubTator, text mining | PubMed |
| Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma. | Cell Rep | 2023 | 37708024 | PubTator, text mining | PubMed |
| mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy. | Cancers (Basel) | 2023 | 37686697 | PubTator, text mining | PubMed |
| Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer. | Front Oncol | 2023 | 37637034 | PubTator, text mining | PubMed |
| Spatially Resolved Transcriptomics Technology Facilitates Cancer Research. | Adv Sci (Weinh) | 2023 | 37632718 | PubTator, text mining | PubMed |
| The Role of c-Abl Tyrosine Kinase in Brain and Its Pathologies. | Cells | 2023 | 37626851 | PubTator, text mining | PubMed |
| Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis. | Front Endocrinol (Lausanne) | 2023 | 37621654 | PubTator, text mining | PubMed |
| Acute osteomyelitis/septic pulmonary embolism associated with familial infections caused by PVL-positive ST6562 MRSA-IVa, a presumptive variant of USA300 clone. | IJID Reg | 2023 | 37583479 | PubTator, text mining | PubMed |
| Blending an internet-based emotion regulation intervention with face-to-face psychotherapy: Findings from a pilot randomized controlled trial. | Internet Interv | 2023 | 37575677 | PubTator, text mining | PubMed |
| EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets. | Cancers (Basel) | 2023 | 37568780 | PubTator, text mining | PubMed |
| Short- and long-term direct and indirect costs of illness after ostomy creation - a Swedish nationwide registry study. | BMC Health Serv Res | 2023 | 37553576 | PubTator, text mining | PubMed |
| Novel anti‑hepatitis B virus flavonoids sakuranetin and velutin from Rhus retinorrhoea. | Mol Med Rep | 2023 | 37539729 | PubTator, text mining | PubMed |
| Macrophage's role in solid tumors: two edges of a sword. | Cancer Cell Int | 2023 | 37525217 | PubTator, text mining | PubMed |
| Upregulation of EphA4 deteriorate brain damage by shifting microglia M1-polarization via NF-κB signaling after focal cerebral ischemia in rats. | Heliyon | 2023 | 37519758 | PubTator, text mining | PubMed |
| Multi-omic analysis reveals dynamic changes of three-dimensional chromatin architecture during T cell differentiation. | Commun Biol | 2023 | 37488215 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2043/papers?page=8